 |
8-methoxsalen |
|---|---|
| Trade Name | Uvadex |
| Orphan Indication | For use in conjunction with the UVAR photopheresis to treat diffuse systemic sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 1993-06-22 00:00:00 |
| Sponsor | Therakos, Inc.;Oaklands Corporate Center, 437 Creamery Way;Exton, Pennsylvania, 19341 |
